Latest News and Press Releases
Want to stay updated on the latest news?
-
Ligand to Host Investor Day on December 9, 2025
-
Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients
-
Ligand to Participate in September Investor Conferences
-
Ligand Announces Closing of Convertible Senior Notes Offering
-
Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering
-
Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030
-
Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
-
Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025
-
Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™
-
Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics